🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-520598-38-00
Authorised Phase I

Investigating the pharmacokinetics of petrelintide using different drug product concentrations in participants with a BMI ≥27.0 kg/m2

2025-520598-38-00 · tracked via the Priya Life Science EU tracker
Sponsor
Zealand Pharma A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
17/11/2025
Enrollment target
48
Sites
Germany

Condition studied

Weight reduction

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-520598-38-00 on CTIS ↗ ← All trials in the EU